Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.

The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study

Abstract

Background Bipolar disorder (BD) is characterized by episodes of mania and depression. The debilitating symptoms during an acute episode require intensive treatment, frequently leading to inpatient psychiatric care, which places significant demands on health and social care systems and incurs substantial costs. However, no study to date has estimated the economic impact of relapse. Objectives To estimate the direct costs associated with relapse in the treatment of BD following an acute manic or mixed episode over a 21-month follow-up period in routine clinical practice in Europe, using data from a large, prospective, observational study. Methods EMBLEM was a prospective, observational study on the outcomes of patients with a manic/mixed episode of BD conducted in 14 European countries. Patients eligible for analysis were those enrolled in the 21-month maintenance phase of the study, following the 3-month acute phase. Relapse was defined as achieving any one of the following criteria: (i) at least a one-point increase in Clinical Global Impression - Bipolar Disorder (CGI-BP) overall score from the previous visit, with a final rating of > or =4; (ii) inpatient admission for an acute episode of BD; or (iii) psychiatrists' confirmation of relapse. Data on healthcare resource use were recorded retrospectively for the four respective periods (3-6, 6-12, 12-18 and 18-24 month visits). Multivariate analyses were performed to compare the cost of resource use (inpatient stay, day care,…

Overview

Integrity signals

Registry

Crossref · 10.2165/11535200-000000000-00000

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Research works printed but not linked: 4

  1. Curtis L. Unit costs of health and social care 2008. Kent: University of Kent, 2008
  2. American Psychiatric Association. Diagnostic and statistical manual ofmental disorders. 4th ed, text revision (DSM-IVTR). Washington, DC: APA, 2000
  3. Stata Corp. Stata statistical software: release 10. College Station (TX): StataCorp LP, 2007
  4. Goetz I, Tohen M, Reed C, et al. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2006; 8: 1–8

Cited by

See all 26

Metadata

Authors
Hong, J., Reed, C., Novick, D., Haro, J. M., Windmeijer, F., & Knapp, M.
Affiliations
  • Eli Lilly (United Kingdom) (GB)
  • University of Bristol (GB)
  • King's College London (GB)
Corresponding author
Hong, Jihyung
Venue
PharmacoEconomics
Published
2010-07
Volume
28
Issue
7
Pages
555-566
ISSN
  • 1170-7690 (ISSN-L)
  • 1179-2027
OpenAlex
W1995804459
Cited by
26
References
54
Citations by year
2025: 1 · 2024: 4 · 2023: 5 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 3 · 2015: 4 · 2013: 1 · 2012: 2
FWCI
0.86
Type
journal article
Language
en
Open access
closed
Locations
  • PharmacoEconomics (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Economic and Social Research Council (ES/H005331/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Keywords
bipolar disorder, relapse, direct costs, manic episodes, mixed states, health care utilization, inpatient psychiatric hospitalization, maintenance phase, emblematics, economic burden, mental health care costs, drug costs, unit cost, sensitivity analysis, multiple imputation, missing data, routine clinical practice, Europe, United Kingdom
MeSH terms
Adult, Bipolar Disorder, Costs and Cost Analysis, Europe, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Socioeconomic Factors, Multivariate Analysis, Treatment Outcome, Health Care Costs, Models, Economic, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study. https://app.cochat.ai/papers/10.2165/11535200-000000000-00000
The paper
Hong, J., Reed, C., Novick, D., Haro, J. M., Windmeijer, F., & Knapp, M. (2010). The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study. PharmacoEconomics. https://doi.org/10.2165/11535200-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.